NasdaqCM - Nasdaq Real Time Price USD

Co-Diagnostics, Inc. (CODX)

Compare
1.0700 -0.0100 (-0.93%)
At close: November 19 at 4:00 PM EST
1.0700 0.00 (0.00%)
After hours: November 19 at 4:01 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
7,321.0120
6,812.0380
34,218.2090
97,885.6030
74,552.7580
Cost of Revenue
3,711.8970
4,184.9490
5,481.0930
11,574.9440
16,591.3460
Gross Profit
3,609.1150
2,627.0890
28,737.1160
86,310.6590
57,961.4120
Operating Expense
43,608.5950
45,333.3230
40,328.4070
40,245.7070
16,267.7720
Operating Income
-39,999.4800
-42,706.2340
-11,591.2910
46,064.9520
41,693.6400
Net Non Operating Interest Income Expense
1,413.0280
1,161.9130
704.0450
45.6310
97.2150
Other Income Expense
1,201.7450
3,433.7650
-7,959.9880
-474.7880
778.2100
Pretax Income
-37,384.7070
-38,110.5560
-18,847.2340
45,635.7950
42,569.0650
Tax Provision
3,899.5640
-2,777.6910
-4,608.9850
8,977.2310
90.5360
Net Income Common Stockholders
-41,284.2710
-35,332.8650
-14,238.2490
36,658.5640
42,478.5290
Diluted NI Available to Com Stockholders
-41,284.2710
-35,332.8650
-14,238.2490
36,658.5640
42,478.5290
Basic EPS
-1.38
-1.20
-0.45
1.27
1.59
Diluted EPS
-1.38
-1.20
-0.45
1.23
1.52
Basic Average Shares
29,983.0450
29,346.5990
31,479.0280
28,874.5550
26,720.1330
Diluted Average Shares
29,983.0450
29,346.5990
31,479.0280
29,903.6860
28,000.3410
Total Operating Income as Reported
-39,999.4800
-42,706.2340
-26,979.8370
46,064.9520
41,693.6400
Total Expenses
47,320.4920
49,518.2720
45,809.5000
51,820.6510
32,859.1180
Net Income from Continuing & Discontinued Operation
-41,284.2710
-35,332.8650
-14,238.2490
36,658.5640
42,478.5290
Normalized Income
-42,342.9350
-38,422.6135
-8,479.8497
36,694.1811
42,478.7036
Interest Income
1,413.0280
1,161.9130
704.0450
45.6310
97.2150
Net Interest Income
1,413.0280
1,161.9130
704.0450
45.6310
97.2150
EBIT
-39,999.4800
-42,706.2340
-11,591.2910
46,064.9520
41,693.6400
EBITDA
-38,666.4590
-41,475.7600
-10,308.5730
46,400.3150
41,832.2750
Reconciled Cost of Revenue
3,711.8970
4,184.9490
5,481.0930
11,574.9440
16,591.3460
Reconciled Depreciation
1,333.0210
1,230.4740
1,282.7180
335.3630
138.6350
Net Income from Continuing Operation Net Minority Interest
-41,284.2710
-35,332.8650
-14,238.2490
36,658.5640
42,478.5290
Total Unusual Items Excluding Goodwill
1,340.0810
3,333.0620
-7,627.0190
-44.3550
-0.1750
Total Unusual Items
1,340.0810
3,333.0620
-7,627.0190
-44.3550
-0.1750
Normalized EBITDA
-40,006.5400
-44,808.8220
-2,681.5540
46,444.6700
41,832.4500
Tax Rate for Calcs
0.0002
0.0001
0.0002
0.0002
0.0000
Tax Effect of Unusual Items
281.4170
243.3135
-1,868.6197
-8.7379
-0.0004
12/31/2020 - 7/12/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

OPGN OpGen, Inc.
1.9500
0.00%
 
CVRX CVRx, Inc.
13.42
-1.54%
 
CERS Cerus Corporation
1.6800
+0.60%
 
INBS Intelligent Bio Solutions Inc.
1.3800
-2.13%
 
TNON Tenon Medical, Inc.
2.5400
+2.01%
 
TNDM Tandem Diabetes Care, Inc.
27.87
-3.09%
 
LUNG Pulmonx Corporation
6.00
-1.96%
 
SRTS Sensus Healthcare, Inc.
8.37
-0.54%
 
SENS Senseonics Holdings, Inc.
0.3177
+5.16%
 
NAOV NanoVibronix, Inc.
0.6370
-6.19%